PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid Arthritis

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1360
https://www.valueinhealthjournal.com/article/S1098-3015(12)03073-2/fulltext
Title : PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid Arthritis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03073-2&doi=10.1016/j.jval.2012.08.1360
First page : A439
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 857
Categories :
Tags :
Regions :
ViH Article Tags :